Chloroprocaine hydrochloride 3% · ophthalmic gel
Local Anesthetic
Approved uses
Ocular surface anesthesia for a planned procedure
3 drops applied topically to the ocular surface over the area of the planned procedure, reapplied as needed to maintain the effect
A gel rather than a drop, so it stays where it is put; onset and duration are longer than proparacaine
Contraindications
IHEEZO TM is contraindicated in patients with a history of hypersensitivity to any component of this preparation.
3% ophthalmic gel, 24 mg per 800 mg single-patient-use vial (1.25 mL), packages of 1 or 5 vials
Chloroprocaine, like other local anesthetics, blocks the generation and conduction of nerve impulses, presumably by raising the threshold for electrical excitation of the nerve.
Warnings & Precautions
- Not for injection or intraocular administration: IHEEZO TM should not be injected or intraocularly administered.
- Corneal injury due to insensitivity: Patients should not touch the eye for at least 10 to 20 minutes after using anesthetic, as accidental injuries can occur due to insensitivity of the eye.
- Corneal opacification: Prolonged use of a topical ocular anesthetic may produce permanent corneal opacification and ulceration with accompanying visual loss.
- Risk of contamination: Do not touch the dropper tip to any surface, as this may contaminate the gel.
- For administration by healthcare provider: IHEEZO TM is indicated for administration under the direct supervision of a healthcare provider and is not intended for patient self-administration.
Common Side Effects
The most common adverse reactions in these studies, (incidence greater than or equal to 5%) following IHEEZO TM administration were mydriasis, conjunctival hyperemia and eye irritation.
Pregnancy: There are no adequate and well-controlled studies of IHEEZO TM use in pregnant women to inform a drug associated risk, and there are no animal reproduction studies for chloroprocaine.
Lactation: There are no data on the presence of chloroprocaine in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for IHEEZO TM and any potential adverse effects on the breastfed infant from IHEEZO TM.
Safety and effectiveness in pediatric patients have not been established.